Revvity Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 05:45PM GMT
Release Date Price: R$20.86 (+9.56%)
Casey Woodring
JPMorgan Chase & Co - Analyst

All right. Great. Thank you, everybody, for joining us today. I'm Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. Welcome to our conference.

Pleasure to be joined today by the management team of Revvity. I'll pass it off to CEO, Prahlad Singh, for some prepared remarks and go through the presentation, then we'll do Q&A afterwards. So Prahlad, how about it?

Prahlad Singh
Revvity Inc - President, Chief Executive Officer, Director

Thank you, Casey. Good morning. Welcome. We are excited to share with you our story and the progress that we've made over the past 12 months since you heard the conference last. Before I begin, I wanted to invite your attention to our safe harbor statement and encourage you to visit the Investors section on our website, revvity.com, for additional financial disclosures and the latest SEC filings.

All the figures and financials that you'll hear today are all estimated future results and growth rates presented and what we'll talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot